NanoViricides
NNVC
$1.10
Share price
-4.27%
Change (1 day)
-13.99%
Change (1 year)
Categories
Market capitalization of NanoViricides (NNVC)
Market cap: $12.96 Million
As of April 2024 NanoViricides has a market cap of $12.96 Million. This makes NanoViricides the world's 8079th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of NanoViricides from 2007 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $12.96 M | 8.23% |
| 2023 | $11.98 M | -7.03% |
| 2022 | $12.88 M | -69.94% |
| 2021 | $42.87 M | 40.07% |
| 2020 | $30.6 M | 215.06% |
| 2019 | $9.71 M | -30.11% |
| 2018 | $13.9 M | -75.06% |
| 2017 | $55.74 M | -10.5% |
| 2016 | $62.27 M | -8.73% |
| 2015 | $68.23 M | -55.65% |
| 2014 | $0.15 B | -35.95% |
| 2013 | $0.24 B | 221.02% |
| 2012 | $74.82 M | -17.87% |
| 2011 | $91.1 M | -55.35% |
| 2010 | $0.20 B | 81.97% |
| 2009 | $0.11 B | 12.81% |
| 2008 | $99.39 M | 113.89% |
| 2007 | $46.46 M |
End of Day market cap according to different sources
On Apr 24th, 2024 the market cap of NanoViricides was reported to be:
$13.54 Million
$13.54 Million
$13.54 Million
$13.54 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $81.85 B | 631,118.16% | 🇺🇸 USA |
 Merck MRK | $332.01 B | 2,560,276.53% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $90.69 B | 699,321.58% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $83.66 B | 645,067.26% | 🇬🇧 UK |
 Novavax NVAX | $0.55 B | 4,206.14% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $0.85 B | 6,481.54% | 🇺🇸 USA |